{
  "run_date": "2026-02-07T23:05:38.752239+00:00",
  "stocks_scanned": 235,
  "top_picks": [
    {
      "ticker": "TKA",
      "name": "thyssenkrupp AG",
      "exchange": "XETR",
      "index": "DAX",
      "sector": "Industrials",
      "price": 11.655,
      "currency": "EUR",
      "market_cap": 9659455488,
      "pe_ratio": 15.54,
      "forward_pe": 10.92704,
      "roe": 5.0869998,
      "dividend_yield": 129.0,
      "momentum_6m": 19.602403566203286,
      "momentum_12m": 157.50894348275168,
      "rsi_14": 66.40772694967322,
      "alpha_score": 82,
      "score_breakdown": {
        "value": 21,
        "quality": 15,
        "momentum": 25,
        "catalyst": 13,
        "liquidity": 8
      },
      "yahoo_url": "https://finance.yahoo.com/quote/TKA.DE",
      "signal": "HOLD",
      "confidence": "MEDIUM",
      "reasoning": "thyssenkrupp demonstrates solid momentum and projected earnings growth of 26% annually, outperforming its industry peers, alongside improving financial projections like EBITDA rising to \u20ac2,972M.[4][5] However, limited recent news beyond routine corporate events and an upcoming earnings release introduce uncertainty, with a modest ROE of 5.1% tempering enthusiasm in a volatile industrials sector.[user query] Transformation efforts continue, but macroeconomic headwinds persist without clear near-term breakthroughs.[2]",
      "company_overview": "thyssenkrupp AG is a diversified German industrial conglomerate focused on steel production, automotive components, engineering, and materials, operating in a challenging macroeconomic environment while continuing its transformation process.[2] The company held its 27th Annual General Meeting on January 30, 2026, reflecting ongoing governance activities amid a fiscal year running from October 1 to September 30.[1][2] Recent stock performance shows strong momentum with a 157.5% 12-month return, supported by projected earnings growth outpacing the metals and mining industry.[5]",
      "key_developments": [
        "Annual General Meeting occurred on January 30, 2026, marking key shareholder engagement for the year.[2]",
        "Closed period for insider trading in effect from January 13 to February 12, 2026, ahead of Q1 results.[1]",
        "Quiet period ongoing from January 21 to February 11, 2026, limiting capital market communications prior to quarterly reporting.[1]"
      ],
      "catalysts": [
        "Interim report for Q1 2025/2026 (October-December) on February 12, 2026, with live analyst conference call at 11:00 a.m. CET featuring CEO Miguel \u00c1ngel L\u00f3pez and CFO Dr. Axel Hamann.[1][2][3]",
        "Registration for Q1 conference call materials available from February 9, 2026, potentially influencing sentiment.[3]"
      ],
      "risk_factors": [
        "Challenging macroeconomic environment impacting the ongoing transformation process, with potential delays in strategic shifts.[2]",
        "Closed and quiet periods signaling limited visibility until post-February 12 earnings, heightening volatility risks around results.[1]"
      ],
      "sources": [
        "https://www.thyssenkrupp.com/en/investors/calendar",
        "https://www.thyssenkrupp.com/en/investors",
        "https://www.thyssenkrupp.com/en/investors/reporting-and-publications",
        "https://www.marketscreener.com/quote/stock/THYSSENKRUPP-AG-436698/finances/",
        "https://simplywall.st/stocks/de/materials/etr-tka/thyssenkrupp-shares/past",
        "https://eulerpool.com/en/stock/thyssenkrupp-Stock-DE0007500001/NetIncome"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "EN",
      "name": "Bouygues SA",
      "exchange": "EPA",
      "index": "CAC40",
      "sector": "Industrials",
      "price": 48.25,
      "currency": "EUR",
      "market_cap": 18544437248,
      "pe_ratio": 17.545454,
      "forward_pe": 13.719469,
      "roe": 8.397,
      "dividend_yield": 415.00000000000006,
      "momentum_6m": 25.84767816372373,
      "momentum_12m": 60.73101046194995,
      "rsi_14": 69.28839450740628,
      "alpha_score": 78,
      "score_breakdown": {
        "value": 21,
        "quality": 9,
        "momentum": 25,
        "catalyst": 13,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/EN.PA",
      "signal": "HOLD",
      "confidence": "MEDIUM",
      "reasoning": "Bouygues SA is a **diversified French services group** operating in over 80 countries with 200,000 employees across four main business segments: construction (Colas, Bouygues Construction, Bouygues Immobilier), energies & services (Equans), telecoms (Bouygues Telecom), and media (TF1)[2][3]. The stock has demonstrated strong momentum, with a 6-month return of +25.8% and 12-month return of +60.7%, though recent technical analysis suggests consolidation rather than continued acceleration.",
      "company_overview": "Bouygues SA is a **diversified French services group** operating in over 80 countries with 200,000 employees across four main business segments: construction (Colas, Bouygues Construction, Bouygues Immobilier), energies & services (Equans), telecoms (Bouygues Telecom), and media (TF1)[2][3]. The stock has demonstrated strong momentum, with a 6-month return of +25.8% and 12-month return of +60.7%, though recent technical analysis suggests consolidation rather than continued acceleration.",
      "key_developments": [
        "**Share capital structure confirmed**: As of January 31, 2026, Bouygues has 385,439,418 shares outstanding with 496,550,003 exercisable voting rights, reflecting the company's current capitalization structure[2][3]."
      ],
      "catalysts": [
        "**Full-year 2025 earnings release**: Upcoming financial results will provide clarity on execution across all four business segments and validate the strong stock performance."
      ],
      "risk_factors": [
        "**Technical deterioration**: Volume declining while prices rise indicates potential loss of conviction among buyers, risking sharp corrections if support levels ($9.02-$8.88) are breached[1]."
      ],
      "sources": [
        "https://stockinvest.us/stock/BOUYY",
        "https://live.euronext.com/en/products/equities/company-news/2026-02-02-bouygues-monthly-disclosure-total-number-shares-and",
        "https://www.globenewswire.com/news-release/2026/02/02/3230458/0/en/bouygues-monthly-disclosure-of-the-total-number-of-shares-and-voting-rights.html",
        "https://ng.investing.com/equities/bouygues-n-historical-data"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "AZN",
      "name": "AstraZeneca PLC",
      "exchange": "LSE",
      "index": "FTSE100",
      "sector": "Healthcare",
      "price": 14104.0,
      "currency": "GBP",
      "market_cap": 218651983872,
      "pe_ratio": 31.623316,
      "forward_pe": 18.560966,
      "roe": 21.674,
      "dividend_yield": 173.0,
      "momentum_6m": 27.799927509967382,
      "momentum_12m": 20.387470630408732,
      "rsi_14": 54.043839758125465,
      "alpha_score": 75,
      "score_breakdown": {
        "value": 5,
        "quality": 22,
        "momentum": 25,
        "catalyst": 13,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/AZN.L",
      "signal": "BUY",
      "confidence": "HIGH",
      "reasoning": "AstraZeneca's sustained growth in high-value franchises, deep pipeline with blockbuster potential, and strategic NYSE listing enhance its positioning for long-term revenue ambitions amid a favorable analyst consensus.[1][2] Strong free cash flow supports dividends and buybacks, while oncology and CVRM products demonstrate resilience against pricing pressures.[1] The medium-term uptrend remains intact, with limited downside risk above key support levels.[1]",
      "company_overview": "AstraZeneca PLC is a leading global biopharmaceutical company focused on oncology, cardiovascular, renal & metabolism (CVRM), and respiratory & immunology (R&I) franchises, with strong momentum in products like Tagrisso, Enhertu, and Farxiga driving double-digit growth.[1] The company maintains a robust late-stage pipeline and has recently harmonized its global listings by adding ordinary share trading on the NYSE under the AZN ticker alongside LSE and Nasdaq Stockholm.[2] Shares have delivered +27.8% returns over 6 months and +20.4% over 12 months, trading near record highs with a consensus analyst 'strong buy' rating and price target ~7% above current levels.[1]",
      "key_developments": [
        "AstraZeneca initiated trading of ordinary shares on the NYSE under AZN, replacing prior American Depositary Shares to broaden access to the world's largest capital market while retaining LSE and Nasdaq Stockholm listings; US dollar bonds also transitioned to NYSE.[2]",
        "Reaffirmed long-term ambition of $80 billion in annual revenue by 2030 and launching 20 new medicines, supported by recent pipeline readouts with peak revenue potential exceeding $10 billion.[2]",
        "Upcoming full-year 2025 results on 10 February 2026 expected to show solid revenue and EPS growth across key franchises, amid focus on oncology momentum, margin sustainability, and 2026 guidance.[1]"
      ],
      "catalysts": [
        "Full-year 2025 earnings release on 10 February 2026, with updates on revenue growth, oncology performance, margins, pipeline progress (e.g., regulatory submissions, trial outcomes), and 2026 guidance.[1]",
        "Pipeline milestones, including late-stage readouts in oncology, cardiovascular, and rare diseases representing over $10 billion peak revenue opportunity.[1][2]"
      ],
      "risk_factors": [
        "Earnings misses on revenue momentum, margin compression from R&D costs/pricing pressures in US/Europe, or weak 2026 guidance could pressure sentiment.[1]",
        "Competitive biotech landscape and regulatory/reimbursement challenges in key markets impacting product uptake.[1]"
      ],
      "sources": [
        "https://www.ig.com/uk/news-and-trade-ideas/_astrazeneca-full-year-earnings--can-the-pharma-giant-maintain-o-260204",
        "https://www.stocktitan.net/sec-filings/AZN/6-k-astrazeneca-plc-current-report-foreign-issuer-5cf8521c5fa8.html"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "FERG",
      "name": "Ferguson Enterprises Inc.",
      "exchange": "LSE",
      "index": "FTSE100",
      "sector": "Industrials",
      "price": 19170.0,
      "currency": "GBP",
      "market_cap": 38471598080,
      "pe_ratio": 26.260273,
      "forward_pe": 23.096275,
      "roe": 33.404,
      "dividend_yield": 138.0,
      "momentum_6m": 16.616244059754326,
      "momentum_12m": 31.685590830856224,
      "rsi_14": 64.28571428571428,
      "alpha_score": 71,
      "score_breakdown": {
        "value": 9,
        "quality": 22,
        "momentum": 25,
        "catalyst": 5,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/FERG.L",
      "signal": "BUY",
      "confidence": "HIGH",
      "reasoning": "Ferguson Enterprises is a leading distributor of plumbing, heating, and cooling products serving residential, commercial, and industrial customers across North America. The company operates through two primary segments: U.S. operations (approximately 95% of revenue) and Canadian operations, with a diversified customer base spanning residential trade, commercial/mechanical, waterworks, and HVAC segments. Ferguson has demonstrated strong financial momentum, with Q1 FY2026 (quarter ended October 31, 2025) showing solid operational execution despite mixed market conditions.[1][3]",
      "company_overview": "Ferguson Enterprises is a leading distributor of plumbing, heating, and cooling products serving residential, commercial, and industrial customers across North America. The company operates through two primary segments: U.S. operations (approximately 95% of revenue) and Canadian operations, with a diversified customer base spanning residential trade, commercial/mechanical, waterworks, and HVAC segments. Ferguson has demonstrated strong financial momentum, with Q1 FY2026 (quarter ended October 31, 2025) showing solid operational execution despite mixed market conditions.[1][3]",
      "key_developments": [
        "**Q1 FY2026 Results (December 9, 2025):** Ferguson reported net sales of $8.2 billion, up 5.1% year-over-year, driven by 4.2% organic growth and 1% acquisition growth (Moore Supply Company acquisition in HVAC).[1][3]"
      ],
      "catalysts": [
        "**Non-Residential Infrastructure Spending:** Continued strength in commercial/mechanical and waterworks segments driven by public works projects and municipal spending, which demonstrated 12-21% growth in Q1.[3]"
      ],
      "risk_factors": [
        "**Residential Market Deterioration:** Weakness in residential trade plumbing and HVAC segments (down 4-6% in Q1) reflects soft housing starts and permit activity; further deterioration could pressure overall profitability given this represents 25% of U.S. sales.[3]"
      ],
      "sources": [
        "https://www.moomoo.com/news/post/62629271/ferguson-enterprises-inc-ferg-q1-2026-earnings-call-transcript-summary",
        "https://quartr.com/companies/ferguson-enterprises-inc_3672",
        "https://www.investing.com/news/company-news/ferguson-q1-2026-slides-eps-miss-triggers-stock-decline-despite-revenue-beat-93CH-4398910",
        "https://www.youtube.com/watch?v=ZKruzocZHyc",
        "https://www.corporate.ferguson.com/investor/events-results-and-reports/default.aspx",
        "https://www.corporate.ferguson.com/investor/why-ferguson/default.aspx",
        "https://www.corporate.ferguson.com/pressroom/news-releases/news-details/2025/Ferguson-Reports-Quarter-Ended-October-31-2025/default.aspx",
        "https://www.marketbeat.com/stocks/NYSE/FERG/earnings/"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "ENR",
      "name": "Siemens Energy AG",
      "exchange": "XETR",
      "index": "DAX",
      "sector": "Industrials",
      "price": 152.0,
      "currency": "EUR",
      "market_cap": 130012315648,
      "pe_ratio": 95.0,
      "forward_pe": 28.98324,
      "roe": 16.816,
      "dividend_yield": 46.0,
      "momentum_6m": 58.33333333333333,
      "momentum_12m": 166.19965685093595,
      "rsi_14": 71.95574684426185,
      "alpha_score": 70,
      "score_breakdown": {
        "value": 5,
        "quality": 22,
        "momentum": 23,
        "catalyst": 13,
        "liquidity": 7
      },
      "yahoo_url": "https://finance.yahoo.com/quote/ENR.DE",
      "signal": "BUY",
      "confidence": "HIGH",
      "reasoning": "Analysts' upgraded targets (\u20ac164-\u20ac170) reflect confidence in execution, record orders, and energy-transition tailwinds, outpacing the current \u20ac152 price amid 186% annual gains and technical strength above key moving averages.[1] Revenue growth forecasts of 12% annually match industry peers but are underpinned by superior momentum and margin improvements, justifying a premium P/S ratio despite elevated valuations.[2][3] Recent dividend initiation signals financial health, supporting further upside in a favorable macro for electrification and grids.[3][5]",
      "company_overview": "Siemens Energy AG is a Germany-based energy technology company providing equipment and services for power generation, grids, and energy-transition projects, with a strong market position driven by structural demand in grid infrastructure and renewables.[1] The company has delivered robust financial performance, including double-digit comparable revenue growth (13% last year), record order intake, and an upgraded mid-term outlook through 2028, supporting a sharp stock recovery from \u20ac13.85 in early 2024 to around \u20ac152 as of early February 2026.[1][3] It forecasts 11-13% revenue growth and 9-11% profit margin before special items for fiscal 2026, positioning it toward the upper end of guidance after strong quarterly results.[3]",
      "key_developments": [
        "Deutsche Bank raised its price target to \u20ac170 from \u20ac135 (29 January 2026), citing improved fundamentals, stronger order pipeline, profitability, and demand for grid/energy-transition infrastructure.[1]",
        "Jefferies lifted its target to \u20ac164 from \u20ac134 (2 February 2026), highlighting better earnings visibility and supportive sector dynamics in grid investments.[1]",
        "Company announced a \u20ac0.70 dividend following early exit from the federal Bund Back Guarantee, lifting the dividend ban earlier than expected, alongside strong Q results trending toward upper-end FY guidance.[3][5]"
      ],
      "catalysts": [
        "Fiscal 2026 results and guidance confirmation, with current trends toward upper-end of 11-13% revenue growth and 9-11% margins.[3]",
        "Progress on order backlog execution and energy-transition projects, potentially driving earnings beats amid broker-upgraded outlooks.[1]"
      ],
      "risk_factors": [
        "Elevated P/S ratio (3.4x vs. industry <1.7x) and high P/E (95x) leave room for pullbacks if revenue growth disappoints or fails to accelerate beyond 12% forecasts.[2]",
        "Persistent challenges in legacy onshore wind business and potential project execution risks in a high-expectation environment.[1]"
      ],
      "sources": [
        "https://capital.com/en-int/analysis/siemens-energy-stock-forecast",
        "https://simplywall.st/stocks/de/capital-goods/etr-enr/siemens-energy-shares/news/siemens-energy-ags-etrenr-26-price-boost-is-out-of-tune-with",
        "https://www.siemens-energy.com/global/en/home/investor-relations.html",
        "https://www.investing.com/equities/siemens-energy-ag",
        "https://www.perplexity.ai/finance/ENR.DE"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "SAF",
      "name": "Safran SA",
      "exchange": "EPA",
      "index": "CAC40",
      "sector": "Industrials",
      "price": 308.0,
      "currency": "EUR",
      "market_cap": 128284680192,
      "pe_ratio": 29.758453,
      "forward_pe": 29.628347,
      "roe": 34.745997,
      "dividend_yield": 94.0,
      "momentum_6m": 5.987609611503686,
      "momentum_12m": 26.409959646058656,
      "rsi_14": 39.782594994443805,
      "alpha_score": 70,
      "score_breakdown": {
        "value": 5,
        "quality": 25,
        "momentum": 20,
        "catalyst": 13,
        "liquidity": 7
      },
      "yahoo_url": "https://finance.yahoo.com/quote/SAF.PA",
      "signal": "BUY",
      "confidence": "MEDIUM",
      "reasoning": "Safran's strong backlog, aftermarket resilience, and defense exposure position it well for continued aerospace demand recovery, with consensus price targets implying 9-12% upside from \u20ac308.[1] Recent stock gains and technical strength support momentum, though elevated valuation and overbought signals warrant caution in the near term.[1][3]",
      "company_overview": "Safran SA is a leading French aerospace and defense group specializing in aircraft engines, equipment, and propulsion systems, with strong exposure to civil aftermarket demand and defense activities. The stock has shown robust performance, rising from around \u20ac211 at the end of 2024 to approximately \u20ac308 as of February 6, 2026, supported by revenue growth, improving margins, and a large civil engine backlog amid recovering air traffic.[1][4] It trades at a P/E of 29.8 with ROE of 34.7%, reflecting a premium valuation but high quality and momentum scores (Alpha Score: 70/100).[user query]",
      "key_developments": [
        "Stock reached \u20ac308 (+1.82%) on February 6, 2026, after trading in the \u20ac299-\u20ac305 range earlier in the week (Feb 2-5), indicating short-term stability amid a two-year advance to all-time highs.[3][4]",
        "Recent price hovered near \u20ac321 in early January 2026, above key moving averages (\u20ac278-\u20ac301), with RSI at 71.5 signaling overbought conditions but positive technical trend alignment.[1]",
        "Analyst consensus targets average \u20ac336-\u20ac344 for 12 months (high \u20ac380, low \u20ac315), driven by expectations of earnings growth and sector recovery; no major corporate news in last 30 days beyond routine share capital updates (Dec 15, 2025).[1]"
      ],
      "catalysts": [
        "Q4/Full-year 2025 earnings release (expected early 2026), potentially confirming revenue/margin beats and backlog updates.[1]",
        "Aerospace sector tailwinds from rising air traffic and defense spending amid global tensions.[1]"
      ],
      "risk_factors": [
        "Supply-chain disruptions or certification delays impacting engine deliveries and aftermarket volumes.[1]",
        "Macroeconomic shifts, such as revised airline capacity or sector downturns, pressuring high P/E multiple amid overbought technicals.[1][2]"
      ],
      "sources": [
        "https://capital.com/en-int/analysis/safran-stock-forecast",
        "https://tradingeconomics.com/saf:fp",
        "https://www.investing.com/equities/safran-historical-data",
        "https://www.safran-group.com/finance/safran-share-price",
        "https://www.safran-group.com/finance/glance",
        "https://finbox.com/ENXTPA:SAF/"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "GSK",
      "name": "GSK plc",
      "exchange": "LSE",
      "index": "FTSE100",
      "sector": "Healthcare",
      "price": 2198.0,
      "currency": "GBP",
      "market_cap": 88211988480,
      "pe_ratio": 15.812949,
      "forward_pe": 11.246936,
      "roe": 43.310001,
      "dividend_yield": 328.0,
      "momentum_6m": 56.58391015225654,
      "momentum_12m": 50.047182405412705,
      "rsi_14": 85.63432835820896,
      "alpha_score": 70,
      "score_breakdown": {
        "value": 13,
        "quality": 19,
        "momentum": 23,
        "catalyst": 5,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/GSK.L",
      "signal": "BUY",
      "confidence": "MEDIUM",
      "reasoning": "GSK's strong 2025 momentum in Specialty Medicines and Vaccines, coupled with reaffirmed long-term growth targets and rising dividends, supports continued outperformance despite slower 2026 sales guidance.[1][3][5] The stock's re-rating to 26-year highs reflects market optimism on operational delivery under new leadership, though moderating growth and external pressures temper upside.[2][5][7] At a P/E of 15.8 and Alpha Score of 70/100 (strong momentum/quality), it offers attractive value in a resilient healthcare sector.[user query]",
      "company_overview": "GSK plc is a leading global healthcare company focused on pharmaceuticals, vaccines, and specialty medicines, with strong 2025 performance including 4% turnover growth to \u00a332.7 billion, core operating profit up 11% to \u00a39.8 billion, and core EPS up 12% to 172.0p.[1][3][6] The company holds a robust market position in Respiratory, Immunology & Inflammation (RI&I), Oncology, and HIV, driving double-digit sales growth in Specialty Medicines, while maintaining high ROE at 43.3% and delivering a 56.6% 6-month stock return amid a re-rating to 26-year highs near \u00a320+ per share.[2][5][7] Under new CEO Luke Miels, GSK reaffirmed its 2031 sales outlook of over \u00a340 billion, signaling long-term confidence despite moderating near-term growth.[1][3][5]",
      "key_developments": [
        "Reported strong Q4 and FY 2025 results on February 4, 2026, with Q4 turnover up 6-8% to \u00a38.6 billion, core operating profit up 14-18%, and profit before tax doubling to \u00a3950 million; shares jumped 4-7% post-earnings.[1][3][5][7]",
        "Issued 2026 guidance expecting turnover growth of 3-5%, core operating profit and EPS growth of 7-9% at constant exchange rates, with increased full-year dividend to 70p per share from 66p.[1][2][3][5]",
        "Announced positive Phase III trial results in January 2026 for B-Well 1 and 2, advancing R&D in key areas like Oncology and Vaccines.[6]"
      ],
      "catalysts": [
        "Commercial launches and R&D acceleration in Oncology, Vaccines, and HIV, with 2026 as a key execution year.[1][3][6]",
        "Potential positive readouts from ongoing pipeline, including January 2026 Phase III successes, driving Specialty Medicines low double-digit growth.[1][5][6]"
      ],
      "risk_factors": [
        "Slower 2026 sales growth (3-5%) due to vaccine/General Medicines declines and looming HIV patent losses from 2028, amid competitive pressures.[2][5]",
        "External headwinds like Trump's tariff policies, regulatory changes, moderate leverage (debt-to-equity 1.1), and overbought technicals (RSI 70).[2][5]"
      ],
      "sources": [
        "https://www.nasdaq.com/articles/gsk-q4-results-climb-sees-growth-fy26-backs-2031-sales-view-update",
        "https://www.gurufocus.com/news/8580044/gsk-projects-moderate-growth-in-turnover-and-earnings-by-2026",
        "https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-2025-performance-and-re-affirms-long-term-outlooks/",
        "https://www.ig.com/uk/news-and-trade-ideas/gsk-full-year-earnings--can-the-pharma-giant-deliver-on-post-dem-260203",
        "https://www.voxmarkets.com/articles/gsk-sees-slower-sales-growth-in-2026-as-patent-loss-looms-7c4f7f2",
        "https://www.gsk.com/media/g0lnid23/fy-2025-results-announcement.pdf",
        "https://kalkine.co.uk/news/premium/gsk-plc-at-a-26-year-high-is-the-market-re-rating-the-stock"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "RIO",
      "name": "Rio Tinto Group",
      "exchange": "LSE",
      "index": "FTSE100",
      "sector": "Basic Materials",
      "price": 6843.0,
      "currency": "GBP",
      "market_cap": 111193030656,
      "pe_ratio": 14.716128,
      "forward_pe": 12.113603,
      "roe": 17.158002,
      "dividend_yield": 416.0,
      "momentum_6m": 49.673994048695945,
      "momentum_12m": 36.53139134072427,
      "rsi_14": 66.68874172185431,
      "alpha_score": 70,
      "score_breakdown": {
        "value": 13,
        "quality": 22,
        "momentum": 25,
        "catalyst": 0,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/RIO.L",
      "signal": "BUY",
      "confidence": "MEDIUM",
      "reasoning": "Rio Tinto is a **diversified mining leader** with a market capitalization of approximately $151.14 billion, operating major assets including Pilbara iron ore operations, a 30% stake in Escondida copper mine, and 66% ownership of Oyu Tolgoi in Mongolia[1]. The company reported trailing twelve-month revenue of $53.73 billion with a strong operating margin of 25.39% and net margin of 19.2%, though it faces a 3-year revenue decline of -3.9%[1]. Recent performance has been robust, with the stock delivering 44.7% returns over the past year and 11.5% year-to-date[3].",
      "company_overview": "Rio Tinto is a **diversified mining leader** with a market capitalization of approximately $151.14 billion, operating major assets including Pilbara iron ore operations, a 30% stake in Escondida copper mine, and 66% ownership of Oyu Tolgoi in Mongolia[1]. The company reported trailing twelve-month revenue of $53.73 billion with a strong operating margin of 25.39% and net margin of 19.2%, though it faces a 3-year revenue decline of -3.9%[1]. Recent performance has been robust, with the stock delivering 44.7% returns over the past year and 11.5% year-to-date[3].",
      "key_developments": [
        "**Declined Glencore merger**: Rio Tinto rejected a merger proposal from Glencore, citing disagreements over leadership roles and valuation, reaffirming its commitment to maintaining independence and strategic control[1]."
      ],
      "catalysts": [
        "**2025 Annual Results announcement (19 February 2026)**: Full-year earnings will reveal execution progress on major projects (Simandou ramp-up, Mongolia underground expansion) and provide updated 2026 guidance refinement[6]."
      ],
      "risk_factors": [
        "**Iron ore price weakness**: A sharp decline in iron ore prices would materially compress earnings given Pilbara's $6.7bn EBITDA contribution in H1 2025, particularly with elevated net debt limiting financial flexibility[2]."
      ],
      "sources": [
        "https://www.gurufocus.com/news/8586961/rio-tinto-rio-declines-offer-maintaining-independence",
        "https://www.ebc.com/forex/is-rio-tinto-stock-a-buy-in-2026-rio-stock-guide",
        "https://simplywall.st/stocks/gb/materials/lse-rio/rio-tinto-group-shares/news/has-the-market-fully-reflected-rio-tinto-lserios-strong-rece",
        "https://www.morningstar.com/stocks/xnys/rio/quote",
        "https://www.riotinto.com/en/invest/financial-calendar",
        "https://www.riotinto.com/en/invest/financial-news-performance",
        "https://www.riotinto.com/en/invest/reports"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "AMAT",
      "name": "Applied Materials, Inc.",
      "exchange": "US",
      "index": "NASDAQ_SELECT",
      "sector": "Technology",
      "price": 322.51,
      "currency": "USD",
      "market_cap": 255983124480,
      "pe_ratio": 37.15553,
      "forward_pe": 26.492924,
      "roe": 35.508,
      "dividend_yield": 56.99999999999999,
      "momentum_6m": 75.29526315003756,
      "momentum_12m": null,
      "rsi_14": 48.28819156800613,
      "alpha_score": 70,
      "score_breakdown": {
        "value": 5,
        "quality": 25,
        "momentum": 17,
        "catalyst": 13,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/AMAT",
      "signal": "BUY",
      "confidence": "HIGH",
      "reasoning": "AMAT benefits from structural AI tailwinds boosting semiconductor equipment demand, evidenced by recent analyst upgrades, earnings beats, and a consensus Moderate Buy rating with targets implying ~10-20% upside from $322.51.[1][3][4] Strong fundamentals (ROE 35.5-39.26%, low debt-to-equity 0.32, dividend yield 0.6%) and forward P/E discount to industry peers support sustained momentum, despite near-term YoY earnings/revenue dips.[1][5] Global capex from chipmakers like TSMC positions AMAT as a key \"picks-and-shovels\" play in AI infrastructure.[1][3][4]",
      "company_overview": "Applied Materials, Inc. (AMAT) is a leading provider of manufacturing equipment, services, and software for the semiconductor, display, and related industries, holding a strong position in advanced chipmaking tools amid surging AI-driven demand.[1][4] The stock has delivered robust performance with a 6-month return of +75.3%, YTD return of 20.0%, and 1-year return of 81.0%, recently trading up 6.1% to $322.51 on February 6, 2026, with a market cap of ~$256B, P/E of 37.2, and ROE of 35.5%.[1][4] It beat Q4 FY2025 EPS ($2.17 vs. $2.11 est.) and revenue ($6.80B vs. $6.68B est.), though revenue dipped 3.5% YoY, with Q1 FY2026 guidance of $1.98\u2013$2.38 EPS.[1]",
      "key_developments": [
        "Shares surged 6.1% on February 6, 2026 (intraday high $324.40, volume 8.2M shares), driven by analyst upgrades including Deutsche Bank to $390 (Buy), KeyCorp to $380 (Overweight), and Morgan Stanley to $364 (Overweight); consensus is Moderate Buy with $315 avg. target (24 Buys, 8 Holds).[1]",
        "Stock closed at $318.67 after a -2.96% drop in a recent session, amid broader market weakness and pre-earnings caution, with Q1 FY2026 earnings due February 12 expecting $2.19 EPS (-8% YoY) and $6.89B revenue (-3.9% YoY).[5][2]",
        "Balances AI growth (strong customer capex in data centers, autos, industrial chips) with U.S.-China export scrutiny on high-end equipment, contributing to recent volatility including a 5.8% rally tied to sector equipment boom.[3][4]"
      ],
      "catalysts": [
        "Q1 FY2026 earnings on February 12, 2026, with potential for EPS beat ($2.19 est.) and upbeat AI/manufacturing outlook to drive post-earnings rally.[2][5]",
        "AI-related capex acceleration from hyperscalers and chipmakers, enabling breakout above $320-321 resistance amid sector momentum.[3][4]"
      ],
      "risk_factors": [
        "U.S.-China export restrictions delaying high-end equipment orders/shipments, impacting revenue visibility.[4]",
        "Earnings miss on February 12 or weak guidance amid expected YoY declines, plus sector volatility/rotation out of chip equipment stocks.[2][5][6]"
      ],
      "sources": [
        "https://www.marketbeat.com/instant-alerts/applied-materials-nasdaqamat-trading-up-61-whats-next-2026-02-06/",
        "https://www.nasdaq.com/articles/applied-materials-amat-expected-beat-earnings-estimates-can-stock-move-higher",
        "https://www.tikr.com/blog/applied-materials-surged-6-on-equipment-boom-path-to-a-320-breakout-in-2026",
        "https://simplywall.st/stocks/us/semiconductors/nasdaq-amat/applied-materials/news/applied-materials-balances-ai-growth-opportunity-with-new-ch",
        "https://www.zacks.com/stock/news/2828386/heres-why-applied-materials-amat-fell-more-than-broader-market",
        "https://www.tipranks.com/news/applied-materials-stock-amat-plunges-despite-hopes-for-a-more-constructive-direction"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "DHL",
      "name": "Deutsche Post AG",
      "exchange": "XETR",
      "index": "DAX",
      "sector": "Industrials",
      "price": 49.7,
      "currency": "EUR",
      "market_cap": 57314856960,
      "pe_ratio": 16.188925,
      "forward_pe": 15.037458,
      "roe": 16.792,
      "dividend_yield": 372.0,
      "momentum_6m": 21.72421879525457,
      "momentum_12m": 48.088536973267004,
      "rsi_14": 73.08786675989094,
      "alpha_score": 69,
      "score_breakdown": {
        "value": 18,
        "quality": 16,
        "momentum": 23,
        "catalyst": 5,
        "liquidity": 7
      },
      "yahoo_url": "https://finance.yahoo.com/quote/DHL.DE",
      "signal": "HOLD",
      "confidence": "MEDIUM",
      "reasoning": "DHL Group exhibits earnings resilience and cost discipline, with four consecutive quarters of EBIT growth and reaffirmed FY2025 guidance despite freight weakness and trade volatility.[1][2] However, revenue pressures from currency effects, lower volumes, and segment-specific declines (e.g., Global Forwarding -23-30% EBIT drops) temper upside, aligning with moderate valuation (P/E 16.2) and alpha score.[1][2] Stable cash flows support shareholder returns, but global economic headwinds limit near-term momentum.[5]",
      "company_overview": "Deutsche Post AG (DHL Group), the global logistics leader, provides express shipping, freight forwarding, supply chain solutions, eCommerce, and postal services, with strong market positions in Europe and worldwide.[5] In 2025, the company demonstrated resilient earnings growth amid volatile trade conditions and currency headwinds, achieving Q1 EBIT up 4.5% to \u20ac1.37 billion and Q3 EBIT up 7.6% to \u20ac1.5 billion despite revenue declines in some quarters.[1][2] Divisions like Express and Post & Parcel Germany showed margin improvements, supporting a robust ROE of around 17% and positive cash flow generation.[1][2][7]",
      "key_developments": [
        "Q1 2025 results: Group revenue +2.8% YoY to \u20ac20.8 billion, EBIT +4.5% to \u20ac1.37 billion, net profit +6.2% to \u20ac786 million; strong gains in Post & Parcel Germany (+44.6% EBIT) offset freight declines.[1]",
        "Q3 2025 results: Revenue -2.3% to \u20ac20.1 billion due to currency and US volume drops, but EBIT +7.6% to \u20ac1.5 billion (margin 7.3%); unchanged FY guidance of \u2265\u20ac6 billion EBIT and ~\u20ac3 billion free cash flow.[2]",
        "Analyst consensus (as of Feb 2, 2026): FY2025 net profit ~\u20ac3.5-3.7 billion, EPS \u20ac3.13-3.35; next earnings on March 4, 2026.[3][7]"
      ],
      "catalysts": [
        "Q4 2025 and FY2025 earnings release (expected March 4, 2026), potentially confirming guidance amid year-end seasonal strength.[2][7]",
        "Potential rebound in air/sea freight volumes if trade tensions ease, boosting Global Forwarding performance.[1][2]"
      ],
      "risk_factors": [
        "Persistent trade conflicts and currency volatility impacting revenue, especially US routes and freight segments.[2]",
        "Regulatory pressures and declining letter volumes in Post & Parcel Germany, despite parcel growth offsets.[1][2]"
      ],
      "sources": [
        "https://group.dhl.com/en/media-relations/press-releases/2025/dhl-group-financial-figures-q1-2025.html",
        "https://group.dhl.com/en/media-relations/press-releases/2025/dhl-group-financial-figures-q3-2025.html",
        "https://group.dhl.com/en/investors/shares/consensus.html",
        "https://reporting-hub.group.dhl.com/2025-q3/en/business-performance/",
        "https://group.dhl.com/en/investors.html",
        "https://www.marketscreener.com/news/dhl-consensus-full-year-dhl-consensus-fy-2026-2-2-ce7e5bd2d989fe2c",
        "https://simplywall.st/stocks/bg/transportation/bul-dhl/deutsche-post-shares/past"
      ],
      "target_timeframe": "3-6 months"
    }
  ],
  "dashboard_stats": {
    "has_history": true,
    "total_predictions": 10,
    "evaluated": 0,
    "pending": 10,
    "correct": 0,
    "incorrect": 0,
    "inconclusive": 0,
    "win_rate": null,
    "per_signal": {
      "BUY": {
        "total": 0,
        "correct": 0,
        "decisive": 0,
        "accuracy": null,
        "avg_return": null
      },
      "HOLD": {
        "total": 0,
        "correct": 0,
        "decisive": 0,
        "accuracy": null,
        "avg_return": null
      },
      "AVOID": {
        "total": 0,
        "correct": 0,
        "decisive": 0,
        "accuracy": null,
        "avg_return": null
      }
    },
    "weight_overrides": {},
    "active_weights": {
      "value": 25,
      "quality": 25,
      "momentum": 25,
      "catalyst": 15,
      "liquidity": 10
    },
    "base_weights": {
      "value": 25,
      "quality": 25,
      "momentum": 25,
      "catalyst": 15,
      "liquidity": 10
    },
    "recent_evaluations": [],
    "performance_timeline": [
      {
        "date": "2026-02-07",
        "win_rate": null,
        "total_predictions": 10,
        "evaluated": 0,
        "correct": 0,
        "avg_return": null,
        "buy_accuracy": null,
        "hold_accuracy": null,
        "avoid_accuracy": null
      }
    ]
  }
}